N. Anichkov, Department of Pathology and Physiology, Academy of Medical Sciences, Leningrad, USSR
Atta-ur Rahman, International Center for Chemical and Biological Sciences, University of Karachi
J. Axelrod, National Institute of Mental health, Bethesda MD 20892, USA
W. Birkmayer, Evangelica Hospital, Vienna, Austria
T B. Bolton, Ion Channels &Cell Signaling, Basic Medical Sciences,St George’s University of London
A. F Brading, University Department of Pharmacology, Oxford
G. Burnstock, Autonomic Neuroscience Institute, Royal Free Hospital, School of Medicine, London
B. Cuparencu, Disciplina de Farmakologie a IMF Cluj-Napoca, Cluj-Napoca, Romania
C. T Dollery, Department of Medicine, University of London, London, UK,
S. Ehrenpreis, UHS/The Chicago Medical School, North Chicago, USA
L. Endrényi, Department of Pharmacology and Toxicology, University of Toronto, Toronto, Canada
F. Erjavec, Department of Pharmacology, Medical Faculty, University of Ljubljana, Yugoslavia
S. Fern, Institute of Pharmacology, University of Bologna, Bologna, Italy
G. Feszt, Department of Pharmacology, Medical and Pharmaceutical Institute Tirgu-Mures, Tirgu-Mures, Romania
W. Förster, Department of Pharmacology and Toxicology, Mertin-Luther University, Halle-Wittenberg, GDR
R. B. Furchgott, Department of Pharmacology, Sunny Health Science Center of Brooklyn, NY 11203, USA
V. P. Georgiev, Institute of Physiologiy, Bulgarian Academy of Sciences, Sofia, Bulgaria
V. Z. Gorkin, Institute of Biological and Medical Chemsitry, Academy of Medical Sciences, Moscow, USSR
T. Griesbaclier, Institut für ExperrnentcHe und Klinische Pharinakologie der Medizinischen Universitat, Graz, Austria
R. J. Gryglewski, Department of Pharmacology, Jagiellonian University Medical College, Krakow, Poland
P. Holzer Institut für Experimentelle und Klinische Pharmakologie der Medizinischen Universität Graz, Graz, Austria
S. Hukovic, Department of Pharmacology, Medical Faculty, Sarajevo, Yugoslavia
J. R. Idle, Institute for Cancer Research and Molecular Biology, MediL I Technical Research Centre, Norwegian University of Science and Technolog\ Trondheim, Norway
P. Illés, Leipzig, Germany
H. Iwata, Department of Pharmacology, Faculty of Pharmaceutical Sciences. Osaka University, Osaka, Japan
N. V. Kaverina, Institute of Pharmacology, Academy of Medical Scienc of the USSR, Moscow, USSR
D. A. Kharkevich, 1st Medical Institute, Moscow, USSR
I. P. Lapin, Laboratory of Psychopharmacology, Bekhterey Psychoneuro1 gical Research Institute, Leningrad, USSR
J. Maj, Institute of Pharmacology, Polish Academy of Sciences, Krako’ Poland
F. Markward, Institute of Pharmacology and Toxicology, Medical Acaden Erfurt, Erfurt, GDR
M. Nagano, Department of internal Medicine, Jikei University School of M dicine, Katsushuka-ku, Tokyo, Japan
S. Okabe, Department of Pharmacology, Doshisha University, Kyoto
M. K. Paasonen, Department of Pharmacology, University of Helsinki, 1k sinki, Finland
P. Pacher Laboratory of Physiologic Studies National Institute on Alcoh Abuse and Alcoholism, Bethesda, USA
R. Paoletti, Institute of Pharmacological Scieces, University of Milan, M Ian, Italy
J. R. Parratt, Department of Physiology and Pharmacology, Strathcly Insitute for Biomedical Sciences, University of Strathclyde, Glasgow, S land, UK
V. Petkov, Institute of Physiologiy, Bulgarian Academy of Sciences, Bulgaria
G. Petroianu, Department of Pharmacology and Therapeutics, Faculty of dicine & Health Sciences, United Arab Emirates University, Al Am
K. D. Rainsford, Biomedical Research Centre, Sheffield Hallam Univ’i Sheffield, UK
H. Rang, Novartis Institute for Medical Research, London
H. Raskova, Institute of Pharmacology, Czechoslovak Academy of SCkIG Prague, Czechoslovakia
K. S. Ravevski, 1)cpart i twill of Pharmacology, Academy of Medical Sciences, Moscow, USSR
P. Riederer, Department ol Psychiatry, Clinical Neurochemistry, Wiirzhurg P Ro,nuaidi, Department of Pharmacology, University of Bologna, Bologna, Italy
M. Sandier, Bernhard Baron memorial research Laboratories and Insitute of Obstetrics and Gynecology, Queen Charlotte’s Hospital, London UK
M. Schafer, Department of Anesthesiology and Intensive Care Medicine, Charite University Berlin
A. Schwartz, Institute of Molecular Pharmacology and Biophysics, University of Cincinnati College of Medicine, USA
V. P. Shah, VSP Consulting, LLC, Pharmaceutical Consultant, North Potomac, USA; University of Kentucky, Lexington, USA
Th. P. Singer, Department of Pharmaceutical Chemistry, Biochemistry and Biophysics, University of California, San Francisco, USA
F. Sjoqvist, Department of Clinical Pharmacology, Huddinge University Hospital, Stockholm
K. Starke, Die Geschichte des Pharmakologischen Instituts der Universität Freiburg
S. Szabo, School of Medicine, University of California
K. F. Tipton, Department of Pharmacology, Trinity College, Dublin, Ireland U. Trendeienburg, Department of Pharmacology, University of Wurzburg, Wurzburg, Germany
B. Uvnas, Department of Pharmacology Karoliniska Institute, Stockholm, Sweeden
D. F. van Heiden, The Neuroscience Group, School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, New South Wales, Australia
V. M. Varagic, Department of Pharmacology, Medical Faculty, Belgrade, Yugoslavia
E. M. Vaughan, Williams Hertford College, Oxford, UK
G. Veio, Department of Pharmacology, University of Verona
B. Vrhovac, Division of Clinical Pharmacology, Department of Medicine, Clinical Hospital Centre, Medical School of Zagreb
A. Woiienberger Division of Cellular and Molecular Cardiology, central Insitute for Cardiovascular Research, Academy of Sciences of the GDR, BerlinBuch, GDR
V. V. Zakusov, Institute of Pharmacology, Academy of Medical Sciences of the USSR, Moscow, USSR
